105445-58-7

Basic information

• Product Name: 2-TRIBUTYLSTANNYLBENZOTHIAZOLE
• Synonyms: 2-TRIBUTYLSTANNYLBENZOTHIAZOLE;2-(Tributylstannyl)-1,3-benzothiazole;(1,3-Benzothiazol-2-yl)tributylstannane;Benzothiazole,2-(tributylstannyl)-;2-(tributylstannyl)benzo[d]thiazole;2-Tributylstannanylbenzothiazole
• CAS NO: 105445-58-7
• Molecular Formula: C₁₉H₃₁NSSn
• Molecular Weight: 424.23
• Product Categories: Stannanes
• Mol File: 105445-58-7.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 424.1°C at 760 mmHg
• Flash Point: >110 °C
• Appearance: /
• Density: 1.202 g/mL at 25 °C
• Vapor Pressure: 5.22E-07mmHg at 25°C
• Storage Temp.: Keep Cold
• PKA: 0.89±0.10(Predicted)
• CAS DataBase Reference: 2-TRIBUTYLSTANNYLBENZOTHIAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-TRIBUTYLSTANNYLBENZOTHIAZOLE(105445-58-7)
• EPA Substance Registry System: 2-TRIBUTYLSTANNYLBENZOTHIAZOLE(105445-58-7)

Safety Data

• Hazard Codes: Xi,T,N
• Statements: 21-25-36/38-48/23/25-50/53
• Safety Statements: 36/37/39-45-60-61
• HazardClass: IRRITANT, KEEP COLD, TOXIC
• Hazardous Substances Data: 105445-58-7(Hazardous Substances Data)

Usage

General Description

2-TRIBUTYLSTANNYLBENZOTHIAZOLE is a chemical compound that is a member of the family of benzothiazole. It is used as a heat stabilizer in the production of PVC, and as an inhibitor for the vulcanization of rubber. It is also utilized as a biocidal agent in antifouling paints and as a fungicide. However, it is considered to be toxic to aquatic organisms and to have potential reproductive and developmental toxicity. Due to these concerns, its use is regulated in certain countries and industries.

InChI:InChI=1/C7H4NS.3C4H9.Sn/c1-2-4-7-6(3-1)8-5-9-7;3*1-3-4-2;/h1-4H;3*1,3-4H2,2H3;/rC19H31NSSn/c1-4-7-14-22(15-8-5-2,16-9-6-3)19-20-17-12-10-11-13-18(17)21-19/h10-13H,4-9,14-16H2,1-3H3

Upstream product

• 1123-99-5 2-iodobenzothiazole 
• 813-19-4 bis(tri-n-butyltin) 
• 95-16-9 1,3-Benzothiazole 
• 1461-22-9 tributyltin chloride 

Downstream Products

• 1417719-68-6 C₂₁H₁₄NOPS 
• 1384954-16-8 C₃₄H₁₉N₂OPS₂ 
• 1374263-52-1 tert-Butyl (1-{4-[2-(1,3-benzothiazol-2-yl)-9H-imidazo[1,2-d]pyrido[2,3-b][1,4]benzodiazepin-3-yl]phenyl}cyclobutyl)carbamate 
• 1146949-85-0 3-(1,3-benzothiazol-2-yl)-5-(3-morpholinophenyl)pyrazin-2-amine 

Relevant articles and documents

Efficient one-pot cross-coupling of two aryl halides by stannylation/stille reaction in water under microwave irradiation

A simple and highly efficient one-pot approach has been developed for the Pd(PPh3)4-catalyzed cross-coupling of two different aryl or heteroaryl bromides/iodides. This method involves the combined use of microwave irradiation and water as a single solvent to achieve sequential stannylation and Stille cross-coupling reactions, which allows rapid access to a wide variety of biaryls in good to high yields. Furthermore, utilizing this step-economical protocol, 2,5-dibromopyridine was iteratively diarylated and the Boscalid intermediate was also synthesized in a one-pot manner. Copyright

Cationic Charge-Appended Abnormal Carbenes: Synthesis and Study of Electronically Modified Abnormal N-Heterocyclic Carbenes

A range of palladium complexes featuring electronically modified, imidazole-based abnormal N-heterocyclic carbene (aNHC) ligands have been prepared in the hopes of accessing a new class of cationic aNHC ligands electronically distinct from normal NHCs and aNHCs. These palladium complexes represent the first examples of transition metal-ligated aNHC complexes featuring a cationic moiety adjacent to the abnormal carbene center. It was anticipated that these design principles could facilitate electron transfer between the imidazolinylidene and the cationic heterocycle, thus reducing the electron density at the abnormal carbene center. However, this case study suggests that greater conformational restrictions that allow for heterocycle coplanarity are necessary to achieve significant electron transfer and enable access to a new class of cationic charge-appended aNHCs with unique electronic properties.

SELECTIVE ESTROGEN RECEPTOR MODULATORS

The present invention provides a compound represented by the following formula (I); [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; Ra and Rb are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R' represents 1 to 4 independent hydrogen atoms and the like; and R" represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof.